falseFY20210001447380YesYesNoNoP48MP48MP48MP48MP48MP3YP3Y0.80P3YP1YP2Y0.0208P3Y0.9700014473802020-09-172020-09-1700014473802020-03-022020-03-020001447380us-gaap:RetainedEarningsMember2021-12-310001447380us-gaap:AdditionalPaidInCapitalMember2021-12-310001447380us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001447380mfon:EquityPayableMember2021-12-310001447380us-gaap:RetainedEarningsMember2020-12-310001447380us-gaap:AdditionalPaidInCapitalMember2020-12-310001447380us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001447380mfon:EquityPayableMember2020-12-310001447380us-gaap:RetainedEarningsMember2019-12-310001447380us-gaap:AdditionalPaidInCapitalMember2019-12-310001447380us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001447380mfon:EquityPayableMember2019-12-3100014473802020-09-1700014473802020-03-020001447380us-gaap:CommonStockMember2021-12-310001447380us-gaap:CommonStockMember2020-12-310001447380us-gaap:CommonStockMember2019-12-310001447380us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001447380us-gaap:EmployeeStockOptionMember2020-12-310001447380us-gaap:EmployeeStockOptionMember2019-12-310001447380srt:MinimumMember2020-01-012020-12-310001447380srt:MaximumMember2020-01-012020-12-310001447380mfon:WarrantIssuanceMemberus-gaap:SubsequentEventMember2022-02-072022-02-070001447380mfon:EmployeesMemberus-gaap:RestrictedStockUnitsRSUMembermfon:FortyEightMonthsMember2021-03-262021-03-260001447380mfon:FirstAnniversaryMember2020-12-172020-12-170001447380mfon:FirstAnniversaryMember2020-12-072020-12-070001447380mfon:FirstAnniversaryMember2020-11-052020-11-050001447380mfon:FirstAnniversaryMember2020-04-062020-04-060001447380mfon:FirstAnniversaryMember2020-03-242020-03-240001447380us-gaap:RestrictedStockUnitsRSUMember2021-02-232021-02-230001447380mfon:CreditAgreementMembersrt:DirectorMember2021-11-012021-11-300001447380mfon:AcoaNoteMember2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMember2019-12-012019-12-310001447380us-gaap:SubsequentEventMember2022-02-012022-02-280001447380mfon:UnsecuredPromissoryNotesMember2018-02-012018-02-280001447380us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001447380us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001447380us-gaap:StateAndLocalJurisdictionMember2021-12-310001447380us-gaap:DomesticCountryMember2021-12-310001447380stpr:AZmfon:LeaseStartingFebruary2021Member2021-12-310001447380us-gaap:StateAndLocalJurisdictionMemberus-gaap:EarliestTaxYearMember2020-01-012020-12-310001447380us-gaap:DomesticCountryMemberus-gaap:EarliestTaxYearMember2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMember2021-12-310001447380us-gaap:RetainedEarningsMember2021-01-012021-12-310001447380us-gaap:RetainedEarningsMember2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-01-270001447380mfon:UnsecuredPromissoryNotesMembersrt:DirectorMember2020-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2020-12-310001447380us-gaap:TradeNamesMember2021-01-012021-12-310001447380us-gaap:NoncompeteAgreementsMember2021-01-012021-12-310001447380us-gaap:DevelopedTechnologyRightsMember2021-01-012021-12-310001447380us-gaap:CustomerRelationshipsMember2021-01-012021-12-310001447380srt:MaximumMember2021-01-012021-12-310001447380mfon:PatentsAndTrademarksMember2021-01-012021-12-310001447380us-gaap:TradeNamesMember2020-01-012020-12-310001447380us-gaap:NoncompeteAgreementsMember2020-01-012020-12-310001447380us-gaap:DevelopedTechnologyRightsMember2020-01-012020-12-310001447380us-gaap:CustomerRelationshipsMember2020-01-012020-12-310001447380mfon:PatentsAndTrademarksMember2020-01-012020-12-310001447380us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001447380us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001447380us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001447380us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001447380us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001447380us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001447380us-gaap:TradeNamesMember2021-12-310001447380us-gaap:NoncompeteAgreementsMember2021-12-310001447380us-gaap:DevelopedTechnologyRightsMember2021-12-310001447380us-gaap:CustomerRelationshipsMember2021-12-310001447380mfon:PatentsAndTrademarksMember2021-12-310001447380us-gaap:TradeNamesMember2020-12-310001447380us-gaap:NoncompeteAgreementsMember2020-12-310001447380us-gaap:DevelopedTechnologyRightsMember2020-12-310001447380us-gaap:CustomerRelationshipsMember2020-12-310001447380mfon:PatentsAndTrademarksMember2020-12-310001447380us-gaap:GoodwillMember2021-01-012021-12-310001447380mfon:IntangibleAssetsMember2021-01-012021-12-310001447380us-gaap:GoodwillMember2020-01-012020-12-310001447380mfon:IntangibleAssetsMember2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-01-272021-01-270001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-01-252021-01-250001447380mfon:UnsecuredPromissoryNotesMember2020-12-012020-12-310001447380mfon:UnsecuredPromissoryNotesMembersrt:DirectorMember2019-01-012019-12-310001447380srt:ScenarioForecastMembermfon:AcoaNoteMember2024-02-012024-02-010001447380srt:ScenarioForecastMembermfon:AcoaNoteMember2022-08-012024-02-010001447380mfon:BdcTermLoanMember2021-10-152021-10-150001447380mfon:BdcTermLoanMember2021-09-152021-09-150001447380srt:ScenarioForecastMembermfon:AcoaNoteMember2021-08-012022-07-310001447380mfon:BdcTermLoanMember2021-03-152021-09-140001447380mfon:BdcTermLoanMember2020-05-152021-03-140001447380mfon:WintrustLoanMember2020-01-012020-12-310001447380mfon:BdcTermLoanMember2019-11-152020-05-140001447380mfon:AcoaNoteMember2019-11-012021-07-310001447380mfon:BdcTermLoanMember2019-08-152019-11-140001447380mfon:AcoaNoteMember2016-06-012019-10-310001447380mfon:BdcTermLoanMember2021-01-012021-12-310001447380mfon:ChaseBankMember2021-12-310001447380mfon:BdcTermLoanMember2021-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-07-010001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-06-300001447380mfon:UnsecuredPromissoryNotes4Member2020-11-180001447380mfon:TdBankMember2020-04-220001447380mfon:UnsecuredPromissoryNotes3Member2020-02-260001447380mfon:UnsecuredPromissoryNotesMember2019-12-310001447380mfon:ChaseBankMember2019-04-100001447380mfon:WintrustLoanMember2018-11-140001447380mfon:UnsecuredPromissoryNotesMember2018-02-280001447380mfon:UnsecuredPromissoryNotes5Member2020-12-310001447380mfon:WintrustBankMember2021-01-012021-12-310001447380mfon:WintrustLoanMemberus-gaap:PrimeRateMember2018-11-142018-11-140001447380mfon:UnsecuredPromissoryNotes5Membermfon:PrincipalMember2020-12-312020-12-310001447380mfon:UnsecuredPromissoryNotes5Membermfon:AccruedInterestMember2020-12-312020-12-310001447380mfon:TdBankMember2021-12-310001447380mfon:RelatedPartyNoteMember2021-12-310001447380mfon:AcoaNoteMember2021-12-310001447380mfon:WintrustBankMember2020-12-310001447380mfon:TdBankMember2020-12-310001447380mfon:RelatedPartyNoteMember2020-12-310001447380mfon:ChaseBankMember2020-12-310001447380mfon:BdcTermLoanMember2020-12-310001447380mfon:AcoaNoteMember2020-12-310001447380mfon:TwoCustomersMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001447380mfon:TwoCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001447380mfon:TwoCustomersMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001447380mfon:TwoCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-3100014473802019-12-310001447380us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-310001447380us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-310001447380stpr:AZmfon:LeaseEndingJanuary2021Member2021-12-310001447380stpr:AZmfon:LeaseStartingFebruary2021Member2021-02-280001447380us-gaap:WarrantMember2021-01-012021-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001447380us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001447380us-gaap:WarrantMember2020-01-012020-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001447380us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-310001447380us-gaap:ComputerSoftwareIntangibleAssetMember2020-01-012020-12-310001447380us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310001447380us-gaap:RestrictedStockUnitsRSUMemberus-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001447380mfon:EmployeesMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001447380mfon:BoardOfDirectorsMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001447380us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001447380mfon:WarrantIssuanceMember2021-01-012021-12-310001447380us-gaap:RestrictedStockUnitsRSUMemberus-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:SellingAndMarketingExpenseMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310001447380mfon:BoardOfDirectorsMemberus-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001447380mfon:WarrantIssuanceMember2020-01-012020-12-310001447380us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001447380us-gaap:SubsequentEventMember2022-02-072022-02-070001447380us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001447380us-gaap:CommonStockMember2020-01-012020-12-310001447380us-gaap:EmployeeStockOptionMember2021-12-310001447380mfon:InvestorWarrantMember2019-01-012019-12-310001447380mfon:InvestorWarrantMember2021-12-310001447380mfon:InvestorWarrantMember2020-12-310001447380mfon:InvestorWarrantMember2019-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2021-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2020-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2019-12-310001447380mfon:EmployeesMemberus-gaap:RestrictedStockUnitsRSUMember2021-03-262021-03-260001447380us-gaap:RestrictedStockUnitsRSUMember2020-12-172020-12-170001447380us-gaap:RestrictedStockUnitsRSUMember2020-11-052020-11-050001447380us-gaap:RestrictedStockUnitsRSUMember2020-08-072020-08-070001447380us-gaap:RestrictedStockUnitsRSUMember2020-03-242020-03-240001447380mfon:InvestorWarrantMember2021-01-012021-12-310001447380mfon:InvestorWarrantMember2020-01-012020-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-3100014473802020-12-012020-12-310001447380mfon:WintrustLoanMember2018-11-142018-11-140001447380mfon:TdBankMember2021-01-012021-12-310001447380us-gaap:SubsequentEventMember2022-02-070001447380us-gaap:SalesRevenueNetMember2021-01-012021-12-310001447380us-gaap:AccountsReceivableMember2021-01-012021-12-310001447380us-gaap:SalesRevenueNetMember2020-01-012020-12-310001447380us-gaap:AccountsReceivableMember2020-01-012020-12-310001447380srt:MinimumMember2021-01-012021-12-310001447380us-gaap:RestrictedStockUnitsRSUMember2021-12-152021-12-150001447380us-gaap:RestrictedStockUnitsRSUMember2021-08-112021-08-110001447380us-gaap:RestrictedStockUnitsRSUMember2021-05-122021-05-120001447380mfon:FourIndependentDirectorsMemberus-gaap:RestrictedStockUnitsRSUMember2021-03-262021-03-260001447380srt:MinimumMemberstpr:AZmfon:LeaseStartingFebruary2021Member2021-02-012021-02-280001447380srt:MaximumMemberstpr:AZmfon:LeaseStartingFebruary2021Member2021-02-012021-02-280001447380stpr:CA-NSmfon:LeaseEndingApril2022Member2021-01-012021-12-310001447380stpr:AZmfon:LeaseEndingJanuary2021Member2021-01-012021-12-310001447380mfon:ThirtySixMonthsMember2020-04-062020-04-060001447380mfon:FortyEightMonthsMember2020-04-062020-04-060001447380stpr:AZsrt:ScenarioForecastMembermfon:LeaseStartingFebruary2021Member2021-02-012022-01-310001447380stpr:AZmfon:LeaseStartingFebruary2021Memberus-gaap:SubsequentEventMember2021-02-012022-01-310001447380stpr:CA-NSmfon:LeaseEndingApril2022Member2021-12-310001447380mfon:UnsecuredPromissoryNotes5Member2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMember2019-01-012019-12-310001447380mfon:CreditAgreementMembersrt:DirectorMember2021-12-310001447380mfon:PrincipalMember2020-01-012020-12-310001447380mfon:AccruedInterestMember2020-01-012020-12-310001447380mfon:WarrantIssuanceMember2020-12-012020-12-310001447380mfon:NewWarrantMember2020-12-012020-12-3100014473802021-12-3100014473802020-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-07-012021-07-010001447380mfon:UnsecuredPromissoryNotesMember2021-01-012021-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2021-01-012021-06-300001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2020-11-182020-11-180001447380mfon:UnsecuredPromissoryNotes4Member2020-11-182020-11-180001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2020-02-262020-02-260001447380mfon:UnsecuredPromissoryNotes3Member2020-02-262020-02-260001447380mfon:UnsecuredPromissoryNotesMembersrt:DirectorMember2020-01-012020-12-310001447380mfon:UnsecuredPromissoryNotesMember2019-12-012019-12-310001447380mfon:ChaseBankMember2021-01-012021-12-310001447380mfon:UnsecuredPromissoryNotesMembermfon:CertainInvestorsOfficersAndDirectorsMember2020-12-312020-12-310001447380mfon:UnsecuredPromissoryNotesMember2019-07-022019-07-020001447380mfon:UnsecuredPromissoryNotesMembersrt:DirectorMember2019-07-012019-07-310001447380mfon:CreditAgreementMembersrt:DirectorMember2021-01-012021-12-310001447380mfon:AcoaNoteMember2021-01-012021-12-3100014473802021-12-152021-12-1500014473802021-08-112021-08-1100014473802021-05-172021-05-1700014473802021-03-262021-03-2600014473802020-12-172020-12-1700014473802020-12-072020-12-0700014473802020-11-052020-11-0500014473802020-04-062020-04-0600014473802020-03-242020-03-2400014473802020-01-012020-12-3100014473802021-06-3000014473802022-03-3000014473802021-01-012021-12-31iso4217:CADmfon:customermfon:employeeutr:sqftiso4217:USDxbrli:sharesmfon:itemxbrli:pureiso4217:USDxbrli:shares
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the related notes and other information that are included elsewhere in this Form 10-K. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations, and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward looking statements as a result of a number of factors, including those set forth under the cautionary note regarding “Forward Looking Statements” contained in Item 1.A – “Risk Factors”.
Overview
Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns.
Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to:
Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.
Measure, predict, and boost guest frequency and spend by channel.
Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program.
Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs.
Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A, Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally.
We’re living in a data-driven economy. In fact, by 2003 — when the concept of “big data” became common vernacular in marketing - as much data was being created every two days as had been created in all of time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.
The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands.
Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.
Recent Events
Unsecured Promissory Note Investments in 2020
During the year ended December 31, 2020, we issued to one of our directors, unsecured Notes in the principal aggregate amount of $700,000, which are due and payable two years after issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. We conducted the private placement of our securities in December 2020. The Note holder participated in the warrant exercise described below and settled principal of $1,200,000 of principal under our 2019 and 2020 private placement Notes in addition to accrued interest under the notes totaling $192,208, into 1,113,767 shares of our common stock. As of December 31, 2020, we had $500,000 as a remaining balance of these 2020 Notes and accrued interest of $8,958. This balance of $500,000 in principle and $43,750 in accrued interest was paid in full on June 30, 2021.
On April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program, in the principal aggregate amount of $891,103, which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent (1%) per annum. The note contains a deferral period of six months, for which no interest or principal payments are due. Full forgiveness of the loan was obtained by meeting certain SBA requirements. The entire loan was forgiven on July 21, 2021, at which time the company recorded and extinguishment of debt in the amount of $891,103.
On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022. This note bears interest on the unpaid balance at the rate of zero percent (0%) per annum during the initial term. Under this note no interest or principal payments are due until January 1, 2023. Under the conditions of the loan, twenty-five percent (25%) of the loan will be forgiven if seventy-five percent (75%) is repaid prior to the initial term date.
Unsecured Promissory Note Investments in 2021
During the year ended December 31, 2021, we issued to Talkot Capital LLC, unsecured Notes in the principal aggregate amount of $ 271,875, which are due and payable two years after issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay the advances and accrued interest, in whole or in part, without notice, penalty or charge. As of December 31, 2021, we have $271,875 as a remaining balance of these 2021 Notes and accrued interest of $23,200.
Secured Promissory Note Investments in 2021
During the year ended December 31, 2021, we issued to one of our directors, Secured Notes in the principal aggregate amount of $3, 478,125, including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility, which are due and payable two years after issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay the advances and accrued interest, in whole or in part, without notice, penalty or charge. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, we have $3,278,125 as a remaining balance of these 2021 Notes and accrued interest of $149,040
Warrant Exercises
On February 7, 2022 seventeen warrant holders exercised their common stock purchase warrant for 3,163,190 shares at the exercise price of $.80 per share, resulting in additional capital of $2,530,552. In February of 2022, warrant holders exercised warrants to purchase common stock at $.80 per share. As an inducement for the holder’s exercise of the warrants, we issued the holders 2,530,552 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025.
Results of Operations
Year Ended December 31, 2021 Compared to Year Ended December 31, 2020
Revenues
Revenues consist primarily of a suite of products under the Recurrency platform. The Recurrency platform is comprised of POS Data Capture, Analytics, Offers and Promotions, Predictive Offers, Personalized Receipt Promotions, Customized Mobile Messaging, Belly Loyalty, and other revenues.
Revenues for the twelve months ended December 31, 2021 were $8,174,884, a decrease of $5,081,003, or 38.3%, compared to $13,255,887 for the twelve months ended December 31, 2020. This decrease is primarily due to the reduction of $1,683,274 of revenue from non-recurring engineering fees paid by a large customer to accelerate expanded capabilities of our Offers and Promotions solution in 2020 and a decrease in revenue of $1,683,270 due to restructuring of customer contract related to Smart Receipt services. In addition, there was a decrease in revenue of $600,000 for a contract cancelled in January of 2021.
Cost of Revenues
Cost of revenues consist primarily of cloud-based software licensing fees, short code maintenance expenses, personnel related expenses, and other expenses.
Cost of revenues for the twelve months ended December 31, 2021 was $4,302,370, a decrease of $446,074, or 9%, compared to $4,748,444 for the twelve months ended December 31, 2020. This decrease is primarily due to lower messaging volume and decreased application costs associated with the decrease in volume. The gross profit margin was 47% and 64% for the twelve months ended December 31, 2021 and 2020, respectively. Lower gross profit margin in 2021 is primarily due to the reduction in non-recurring engineering revenues for 2021.
Bad Debt
Bad Debt expense for the twelve months ended December 31, 2021 was $774,312, an increase of $774,312, or 100%, compared to $0 for the twelve months ended December 31, 2020. This increase is due primarily to the restructuring of a large current contract that had 18 months of remaining ASC 606 deductions that were all recognized at the end of 2021.
General and Administrative
General and administrative expenses consist primarily of administrative salaries and personnel related expenses, legal fees, stock-based compensation expense, consulting costs and other expenses.
General and administrative expenses for the twelve months ended December 31, 2021 were $3,584,721, a decrease of $333,214, or 8%, compared to $3,917,935 for the twelve months ended December 31, 2020. The decrease in general and administrative expense was primarily due a decrease in office supplies due to limited use of the office during COVID-19.
Sales and Marketing Expense
Sales and marketing expenses consist primarily of salaries and personnel related expenses, stock-based compensation expense, sales travel, consulting costs and other expenses.
Sales and marketing expenses for the twelve months ended December 31, 2021 were $4,002,565, an increase of $1,676,856, or 72%, compared to $2,325,709 for the twelve months ended December 31, 2020. The increase in 2021 was due to the addition of sales and marketing personnel coupled with new marketing initiatives in the first half of 2021.
Engineering, Research, and Development Expense
Engineering, research, and development expenses consist primarily of salaries and personnel related expenses, stock-based compensation expense, consulting costs and other expenses.
Engineering, research, and development expenses for the twelve months ended December 31, 2021, were $3,583,773, an increase of $48,031 or 1%, compared to $3,535,742 for the twelve months ended December 31, 2020.
Depreciation and Amortization Expense
Depreciation and amortization expense consist of depreciation on our equipment and amortization of our intangible assets.
Depreciation and amortization expenses for the twelve months ended December 31, 2021, were $707,073 an increase of $32,131, or 4.8%, compared to $674,942 for the twelve months ended December 31, 2020. This increase is primarily attributable to the increased amortization of our developed and acquired technologies.
Intangible Asset Impairment
Intangible Asset Impairment expenses for the twelve months ended December 31, 2021 were $8,286, an decrease of $600, or 6.8%, compared to $8,886 for the twelve months ended December 31, 2020.
Goodwill Impairment
Goodwill Impairment expenses for the twelve months ended December 31, 2021 were $85,169, an increase of $85,169, or 100%, compared to $0 for the twelve months ended December 31, 2020. The increase is due to a decrease in expected cash flow for our current Belly products over the next five years.
Interest Income
Interest income consists of stated interest income on our cash balances.
Interest income for the twelve months ended December 31, 2021 was $5, compared to $1,221 for the twelve months ended December 31, 2020. This decrease of $1,216, or 99%, related to lower earnings on cash positions held throughout the year as compared to the prior year.
Interest Expense
Interest expense consists of stated or implied interest expense on our notes payable, amortization of note discounts, and amortization of deferred financing costs.
Interest expense for the twelve months ended December 31, 2021 was $267,966, a decrease of $18,930, or 6.6%, compared to $286,896 for the twelve months ended December 31, 2020. The decrease is primarily attributable to the interest on short- and long-term borrowings during the year.
Loss on Disposal of Fixed Assets
Loss on disposal of fixed assets consists of an asset being disposed of for less than its carrying value.
Loss on disposal of fixed assets for the twelve months ended December 31, 2021 was $880, a decrease of $7,928 or 90%, compared $8,808 to the twelve months ended December 31, 2020. The decrease is due to reduced amount of assets that were disposed of during the year.
Loss on Settlement of Debt
Loss on settlement of debt consists of loss recognized with the conversion of related party notes that were converted to equity.
The loss on settlement for the twelve months ended December 31, 2021 was $0, a decrease of $668,260, or 100%, compared to $668,260 for the twelve months ended December 31, 2020.
Extinguishment of Debt
The gain on extinguishment of debt for the twelve months ended December 31, 2021 was $891,103, an increase of $891,103 or 100%, compared to $0 for the twelve months ending December 31, 2020. The increase was due to full forgiveness of the our Paycheck Protection Program loan.
Foreign Currency
The Company’s financial results are impacted by volatility in the Canadian/U.S. Dollar exchange rate. The average U.S. Dollar exchange rate for the year ended December 31, 2021 and 2020 was $1 Canadian equals $0.79 and $0.75 U.S. Dollars, respectively. The Company’s functional or measurement currency is the U.S. Dollar. Based on a U.S. Dollar functional currency, the following are the key areas impacted by foreign currency volatility:
The Company sells products primarily in U.S. Dollars; therefore, reported revenues are not highly impacted by foreign currency volatility.
A portion of the Company’s expenses are incurred in Canadian Dollars and therefore fluctuate in U.S. Dollars as the U.S. Dollar varies. A weaker U.S. Dollar results in an increase in translated expenses, and a stronger U.S. Dollar results in a decrease.
Changes in foreign currency rates also impact the translated value of the Company’s working capital that is held in Canadian Dollars. Foreign exchange rate fluctuations result in foreign exchange gains or losses based upon movement in the translated value of Canadian working capital into U.S. Dollars.
The change in foreign currency was a loss of $8,661 and a gain of $117 for the years ended December 31, 2021 and 2020, respectively.
Liquidity and Capital Resources
We have $735,424 of cash as of December 31, 2021. We had a net loss of $8.3 million for the year then ended, and we used $4.5 million of cash in our operating activities during 2021. We raised $2,530,552 in warrant conversion in February 2022. While we believe that our additional cash from our warrant conversion along with our expected cash flow from operations, may not be sufficient to fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months.
If our cash reserves prove insufficient to sustain operations, we plan to raise additional capital by selling shares of capital stock or other equity or debt securities. However, there are no commitments or arrangements for future financings in place at this time, and we can give no assurance that such capital will be available on favorable terms or at all. We may need additional financing thereafter until we can achieve profitability. If we cannot, we will be forced to curtail our operations or possibly be forced to evaluate a sale or liquidation of our assets. Any future financing may involve substantial dilution to existing investors.
Although we are actively pursuing financing opportunities, we may not be able to raise cash on terms acceptable to us or at all. There can be no assurance that we will be successful in obtaining additional funding. Financings, if available, may be on terms that are dilutive to our shareholders, and the prices at which new investors would be willing to purchase our securities may be lower than the current price of our ordinary shares. The holders of new securities may also receive rights, preferences or privileges that are senior to those of existing holders of our ordinary shares. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations in the short term.
Cash Flows
| | | | | |
| | | | | |
| For the Year Ended |
| December 31, |
| 2021 | | 2020 |
Net cash provided by (used in): | | | | | |
Operating activities | $ | (4,484,598) | | $ | (1,329,111) |
Investing activities | | (378,472) | | | (297,195) |
Financing activities | | 2,364,722 | | | 4,661,479 |
Effect of foreign currency translation on cash flow | | (49,048) | | | (25,952) |
Net change in cash | $ | (2,547,396) | | $ | 3,009,221 |
Operating Activities
We used cash in operating activities totaling $4,484,598 in 2021 and $1,329,111 in 2020, respectively. The increase in cash used in operating activities in 2020 compared to 2019 was due primarily to the expansion in our sales and marketing departments.
Investing Activities
Investing activities during 2021 included $299,253 of capitalized software development costs, $0 of purchases related to securing new patents and $79,219 of equipment purchases. Investing activities during 2020 included $266,365 of capitalized software development costs, $17,505 of purchases related to securing new patents, and $13,325 of equipment purchases.
Financing Activities
Financing activities for 2021 include net proceeds from the sale of common stock units of $0, proceeds from related party notes payable of $3,206,250 offset by payments on notes payable of $561,528 and payments of related party notes payable of $280,000.
Critical Accounting Policies and Estimates
We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Our management periodically evaluates the estimates and judgments made, including those related to share-based compensation and valuation of the derivative liability. Management bases its estimates and judgments on historical experience and on various factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.
The following critical accounting policies affect the more significant judgments and estimates used in the preparation of the Company’s consolidated financial statements.
Income Taxes
We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Revenue Recognition and Concentrations
Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card or electronic funds transfer. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.
Accounting Standards Update (“ASU“) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues.
We determine revenue recognition through the following steps:
identification of the contract, or contracts, with a customer;
identification of the performance obligations in the contract;
determination of the transaction price;
allocation of the transaction price to the performance obligations in the contract; and
recognition of revenue when, or as, we satisfy a performance obligation.
During the years ended December 31, 2021 and 20120 two customers accounted for 73% and 77% of our revenues, respectively.
Share-based compensation expense
Share-based compensation cost is measured at the date of grant, based on the calculated fair value of the stock-based award, and is recognized as expense over the employee’s requisite service period (generally the vesting period of the award). We estimate the fair value of employee stock options granted using the Black-Scholes Option Pricing Model. Key assumptions used to estimate the fair value of stock options include the exercise price of the award, the fair value of our common stock on the date of grant, the expected option term, the risk-free interest rate at the date of grant, the expected volatility and the expected annual dividend yield on our Company’s common stock. We have elected to account for forfeitures as they occur to determine the amount of compensation cost to be recognized in each period.
Derivative Financial Instruments
We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.
We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Item 8. Financial Statements
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Stockholders of Mobivity Holdings Corp.
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Mobivity Holdings Corp. (the Company) as of December 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2021, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has suffered net losses from operations and has a net capital deficiency, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are discussed in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Revenue Recognition
As discussed in Note 2, the Company recognizes revenue upon transfer of control of promised services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services.
Auditing management’s evaluation of agreements with customers involves significant judgment, given the fact that some agreements require management’s evaluation and allocation of the standalone transaction prices to the performance obligations.
To evaluate the appropriateness and accuracy of the assessment by management, we evaluated management’s assessment in relationship to the relevant agreements.
M&K CPAS, PLLC
We have served as the Company’s auditor since 2012.
Houston, TX
March 30, 2022
Mobivity Holdings Corp.
Consolidated Balance Sheets
| | | | | |
| | | | | |
| December 31, | | December 31, |
| 2021 | | 2020 |
ASSETS | | | | | |
Current assets | | | | | |
Cash | $ | 735,424 | | $ | 3,282,820 |
Accounts receivable, net of allowance for doubtful accounts of $56,340 and $33,848, respectively | | 578,303 | | | 305,693 |
Contracts receivable, current | | — | | | 943,904 |
Other current assets | | 227,458 | | | 272,736 |
Total current assets | | 1,541,185 | | | 4,805,153 |
Goodwill | | 411,183 | | | 496,352 |
Right to use lease assets | | 1,187,537 | | | 57,482 |
Intangible assets, net | | 1,124,720 | | | 1,368,329 |
Contracts receivable, long term | | — | | | 1,415,856 |
Other assets | | 173,325 | | | 25,230 |
TOTAL ASSETS | $ | 4,437,950 | | $ | 8,168,402 |
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | | | | | |
Current liabilities | | | | | |
Accounts payable | $ | 3,823,909 | | $ | 1,935,411 |
Accrued interest | | 172,239 | | | 47,316 |
Accrued and deferred personnel compensation | | 495,533 | | | 224,881 |
Deferred revenue and customer deposits | | 377,170 | | | 606,597 |
Related party notes payable, net - current maturities | | 819,531 | | | 80,000 |
Notes payable, net - current maturities | | 69,052 | | | 561,676 |
Operating lease liability | | 229,240 | | | 58,173 |
Other current liabilities | | 9,071 | | | 566,303 |
Total current liabilities | | 5,995,745 | | | 4,080,357 |
| | | | | |
Non-current liabilities | | | | | |
Related party notes payable, net - long-term | | 2,498,711 | | | 500,000 |
Notes payable, net - long-term | | 39,086 | | | 999,001 |
Operating lease liability | | 1,188,589 | | | 13,296 |
Other long-term liabilities | | — | | | 831,535 |
Total non-current liabilities | | 3,726,386 | | | 2,343,832 |
Total liabilities | | 9,722,131 | | | 6,424,189 |
Commitments and Contingencies (See Note 13) | | | | | |
Stockholders' equity (deficit) | | | | | |
Common stock, $0.001 par value; 100,000,000 shares authorized; 55,410,695 and 55,410,695, shares issued and outstanding | | 55,411 | | | 55,411 |
Equity payable | | 100,862 | | | 100,862 |
Additional paid-in capital | | 102,446,921 | | | 101,186,889 |
Accumulated other comprehensive income (loss) | | (52,088) | | | (23,446) |
Accumulated deficit | | (107,835,287) | | | (99,575,503) |
Total stockholders' equity (deficit) | | (5,284,181) | | | 1,744,213 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ | 4,437,950 | | $ | 8,168,402 |
See accompanying notes to consolidated financial statements.
Mobivity Holdings Corp.
Consolidated Statements of Operations and Comprehensive Loss
| | | | | |
| | | | | |
| For the Year Ended |
| December 31, |
| 2021 | | 2020 |
Revenues | | | | | |
Revenues | $ | 8,174,884 | | $ | 13,255,887 |
Cost of revenues | | 4,302,370 | | | 4,748,444 |
Gross profit | | 3,872,514 | | | 8,507,443 |
Operating expenses | | | | | |
Bad Debt | | 774,312 | | | — |
General and administrative | | 3,584,721 | | | 3,917,935 |
Sales and marketing | | 4,002,565 | | | 2,325,709 |
Engineering, research, and development | | 3,583,773 | | | 3,535,742 |
Goodwill Impairment | | 85,169 | | | — |
Intangible asset impairment | | 8,286 | | | 8,886 |
Depreciation and amortization | | 707,073 | | | 674,942 |
Total operating expenses | | 12,745,899 | | | 10,463,214 |
Loss from operations | | (8,873,385) | | | (1,955,771) |
Other income/(expense) | | | | | |
Interest income | | 5 | | | 1,221 |
Gain on Extinguishment of Debt | | 891,103 | | | — |
Interest expense | | (267,966) | | | (286,896) |
Loss on disposal of fixed assets | | (880) | | | (8,808) |
Loss on settlement of debt | | — | | | (668,260) |
Foreign currency gain (loss) | | (8,661) | | | 117 |
Total other income (expense) | | 613,601 | | | (962,626) |
Loss before income taxes | | (8,259,784) | | | (2,918,397) |
Income tax expense | | — | | | — |
Net Loss | | (8,259,784) | | | (2,918,397) |
Other comprehensive income (loss), net of income tax | | | | | |
Foreign currency translation adjustments | | (28,642) | | | (32,226) |
Comprehensive loss | $ | (8,288,426) | | $ | (2,950,623) |
Net loss per share: | | | | | |
Basic and Diluted | $ | (0.15) | | $ | (0.06) |
Weighted average number of shares: | | | | | |
Basic and Diluted | | 55,410,695 | | | 51,575,454 |
See accompanying notes to consolidated financial statements.
Mobivity Holdings Corp.
Consolidated Statement of Stockholders' Equity (Deficit)
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Common Stock | | Equity | | Additional | | Accumulated Other | | Accumulated | | Total Stockholders' |
| Shares | | Dollars | | Payable | | Paid-in Capital | | Comprehensive Income (Loss) | | Deficit | | Equity (Deficit) |
Balance, December 31, 2019 | 51,380,969 | | $ | 51,381 | | $ | 100,862 | | $ | 94,781,738 | | $ | 8,780 | | $ | (96,657,106) | | $ | (1,714,345) |
Issuance of common stock for cash | 1,556,459 | | | 1,556 | | | — | | | 1,932,411 | | | — | | | — | | | 1,933,967 |
Issuance of common stock for debt settlement | 1,359,500 | | | 1,360 | | | — | | | 1,639,448 | | | — | | | — | | | 1,640,808 |
Issuance of common stock for warrants exercised | 1,113,767 | | | 1,114 | | | — | | | 2,059,354 | | | — | | | — | | | 2,060,468 |
Stock based compensation | — | | | — | | | — | | | 773,938 | | | — | | | — | | | 773,938 |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | (32,226) | | | — | | | (32,226) |
Net loss | — | | | — | | | — | | | — | | | — | | | (2,918,397) | | | (2,918,397) |
Balance, December 31, 2020 | 55,410,695 | | $ | 55,411 | | $ | 100,862 | | $ | 101,186,889 | | $ | (23,446) | | $ | (99,575,503) | | $ | 1,744,213 |
Fair value of options issued with related party debt | — | | | — | | | — | | | 262,758 | | | — | | | — | | | 262,758 |
Stock based compensation | — | | | — | | | — | | | 997,274 | | | — | | | — | | | 997,274 |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | (28,642) | | | — | | | (28,642) |
Net loss | — | | | — | | | — | | | — | | | — | | | (8,259,784) | | | (8,259,784) |
Balance, December 31, 2021 | 55,410,695 | | $ | 55,411 | | $ | 100,862 | | $ | 102,446,921 | | $ | (52,088) | | $ | (107,835,287) | | $ | (5,284,181) |
See accompanying notes to consolidated financial statements.
Mobivity Holdings Corp.
Consolidated Statements of Cash Flows
| | | | | |
| | | | | |
| For the Year Ended |
| December 31, |
| 2021 | | 2020 |
OPERATING ACTIVITIES | | | | | |
Net loss | $ | (8,259,784) | | $ | (2,918,397) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | |
Bad debt expense | | 774,312 | | | 25,583 |
Loss on settlement of debt | | — | | | 668,260 |
Gain on Extinguishment of Debt | | (891,103) | | | |
Stock-based compensation | | 997,274 | | | 773,938 |
Loss on disposal of fixed assets | | 880 | | | 8,808 |
Intangible Asset Impairment | | 8,286 | | | 8,886 |
Goodwill Impairment | | 85,169 | | | |
Depreciation and amortization expense | | 707,073 | | | 696,574 |
Amortization of debt discount | | 31,000 | | | — |
Increase (decrease) in cash resulting from changes in: | | | | | |
Accounts receivable | | (365,213) | | | 282,734 |
Contracts receivable, current | | — | | | (416,956) |
Other current assets | | 40,133 | | | 338,233 |
Operating lease assets/liabilities | | (2,575) | | | (33,590) |
Contracts receivable, long-term | | 707,928 | | | (155,485) |
Other assets | | 2,330 | | | 14,040 |
Accounts payable | | 1,888,498 | | | (1,321,012) |
Accrued interest | | 168,673 | | | 204,232 |
Accrued and deferred personnel compensation | | 270,590 | | | (20,402) |
Other liabilities - non-current | | (415,766) | | | 91,317 |
Other liabilities - current | | (2,876) | | | 257,838 |
Deferred revenue and customer deposits | | (229,427) | | | 166,288 |
Net cash used in operating activities | | (4,484,598) | | | (1,329,111) |
INVESTING ACTIVITIES | | | | | |
Purchases of equipment | | (79,219) | | | (13,325) |
Cash paid for patents | | — | | | (17,505) |
Capitalized software development costs | | (299,253) | | | (266,365) |
Net cash used in investing activities | | (378,472) | | | (297,195) |
FINANCING ACTIVITIES | | | | | |
Payments on notes payable | | (561,528) | | | (473,586) |
Payments on related party notes payable | | (280,000) | | | (60,700) |
Proceeds from notes payable | | — | | | 920,990 |
Proceeds from related party notes payable | | 3,206,250 | | | 700,000 |
Proceeds from issuance of common stock, net of issuance costs | | — | | | 3,574,775 |
Net cash provided by financing activities | | 2,364,722 | | | 4,661,479 |
| | | | | |
Effect of foreign currency translation on cash flow | | (49,048) | | | (25,952) |
| | | | | |
Net change in cash | | (2,547,396) | | | 3,009,221 |
Cash at beginning of period | | 3,282,820 | | | 273,599 |
Cash at end of period | $ | 735,424 | | $ | 3,282,820 |
Supplemental disclosures: | | | | | |
Cash paid during period for: | | | | | |
Interest | $ | 68,389 | | $ | 75,464 |
Taxes | $ | — | | $ | 851 |
Non cash investing and financing activities: | | | | | |
Initial ROU asset and lease liability | $ | 1,458,527 | | $ | 1,392,208 |
Debt Discount on Related Party Debt | $ | 262,658 | | $ | — |
Fixed Assets contribution by lessor | $ | 110,000 | | $ | — |
Refinancing of debt-related party | $ | 43,750 | | $ | — |
See accompanying notes to consolidated financial statements.
Mobivity Holdings Corp.
Notes to Consolidated Financial Statements
1. Nature of Operations
Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns.
Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to:
Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.
Measure, predict, and boost guest frequency and spend by channel.
Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program.
Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs.
Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A, Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally.
We’re living in a data-driven economy. In fact, by 2003 — when the concept of “big data” became common vernacular in marketing - as much data was being created every two days as had been created in all of time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.
The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands.
Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.
We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.
2. Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Live Lenz Inc. All significant intercompany balances and transactions have been eliminated.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.
Acquisitions
We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents
We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations
Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.
As of December 31, 2021 and 2020, we recorded an allowance for doubtful accounts of $56,340 and $33,848, respectively.
From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred.
As of December 31, 2021, we had three customer whose balance represented 94% of total accounts receivable. As of December 31, 2020, we had two customers whose balance represented 77% of total accounts receivable.
Goodwill and Intangible Assets
Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.
We conducted our annual impairment tests of goodwill as of December 31, 2021 and 2020. As a result of these tests, we a total impairment charges of $85,169.
Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
The Company’s evaluation of its long-lived assets completed resulted in $8286 and $0 of intangible impairment expense during the years ended December 31, 2021 and December 31, 2020.
Software Development Costs
Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense.
Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period.
The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2021 and $8,886 for the year ended December 31, 2020.
Impairment of Long-Lived Assets
We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation
The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.
Derivative Financial Instruments
We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.
We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
Revenue Recognition and Concentrations
Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.
During the years ended December 31, 2021 and 2020, two customers accounted for 55% and 77% of our revenues, respectively.
Comprehensive Income (Loss)
Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve months ended December 31, 2021 and 2020, the comprehensive loss was $8,288,426 and $2,950,623 respectively.
Stock-based Compensation
We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures
Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense
Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $962,049 and $399,266 for years ended December 31, 2021 and 2020, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $50,267 and $81,852 of expense related to those activities for the years ended December 31, 2021 and 2020, respectively.
Income Taxes
We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Computation of Net Loss per Common Share
Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive.
We had the following dilutive common stock equivalents as of December 31, 2021 and 2020 which were excluded from the calculation because their effect was anti-dilutive.
| | | |
| | | |
| December 31, |
| 2021 | | 2020 |
Outstanding employee options | 6,246,466 | | 6,007,552 |
Outstanding restricted stock units | 1,685,141 | | 1,436,728 |
Outstanding warrants | 3,246,690 | | 2,691,459 |
| 11,178,297 | | 10,135,739 |
Recent Accounting Pronouncements
Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments.
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”). ASU No. 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The company adopted January 1, 2022.
3. Going Concern
We have $735,424 of cash as of December 31, 2021. We had a net loss of $8.3 million for the year then ended, and we used $4.5 million of cash in our operating activities during 2021. In 2020, we had a net loss of $2.9 million and used $1.3 million of cash in our operating expenses. We raised $2,530,552 in cash exercise of warrants in February 2022. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will be sufficient to fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months.
As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $107,835,287 as of December 31, 2021. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
4. Goodwill and Intangible Assets
Goodwill
The following table presents goodwill and impairment for the years ended December 31, 2021 and 2020:
| | |
| | |
| Goodwill |
December 31, 2019 | $ | 496,352 |
Acquired | | — |
Impairment | | — |
December 31, 2020 | | 496,352 |
Acquired | | — |
Impairment | | (85,169) |
December 31, 2021 | $ | 411,183 |
We conducted our annual impairment test of goodwill as of December 31, 2021 and 2020, which resulted in impairment charges of $85,169.
Intangible assets
The following table presents components of identifiable intangible assets for the years ended December 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 | | December 31, 2020 |
| Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Weighted Average Useful Life (Years) | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Weighted Average Useful Life (Years) |
Patents and trademarks | $ | 105,543 | | $ | (47,948) | | $ | 57,595 | | 14 | | $ | 197,528 | | $ | (126,499) | | $ | 71,029 | | 14 |
Customer and merchant relationships | | 2,321,112 | | | (1,775,579) | | | 545,533 | | 10 | | | 2,321,112 | | | (1,678,727) | | | 642,385 | | 10 |
Trade name | | 197,955 | | | (165,562) | | | 32,393 | | 10 | | | 197,950 | | | (156,506) | | | 41,444 | | 10 |
Acquired technology | | 621,030 | | | (508,839) | | | 112,191 | | 10 | | | 621,030 | | | (492,539) | | | 128,491 | | 10 |
Non-compete agreement | | 79,300 | | | (50,088) | | | 29,212 | | 2 | | | 79,300 | | | (34,228) | | | 45,072 | | 2 |
| $ | 3,324,940 | | $ | (2,548,017) | | $ | 776,924 | | | | $ | 3,416,920 | | $ | (2,488,499) | | $ | 928,421 | | |
During the years ended December 31, 2021 and 2020, we recorded amortization expense related to our intangible assets of $163,760 and $150,701, respectively, which is included in depreciation and amortization in the consolidated statement of operations.
During the years ended December 31, 2021 and 2020, we recorded impairment of $8,286 and $0 respectively related to our intangible assets.
Expected future intangible asset amortization as of December 31, 2021 is as follows:
| | |
| | |
Year ending December 31, | Amount |
2022 | $ | 142,945 |
2023 | | 140,435 |
2024 | | 103,839 |
2025 | | 96,091 |
2025 | | 96,091 |
Thereafter | | 197,523 |
Total | $ | 776,924 |
5. Software Development Costs
The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The balance is included in the net intangible assets on the balance sheet.
The following table presents details of our software development costs for the years ended December 31, 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
December 31, 2021 | | December 31, 2020 |
Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Weighted Average Useful Life (Years) | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Weighted Average Useful Life (Years) |
$ | 2,565,525 | | $ | (2,217,729) | | $ | 347,796 | | 2 | | $ | 2,266,272 | | $ | (1,826,364) | | $ | 439,908 | | 2 |
$ | 2,565,525 | | $ | (2,217,729) | | $ | 347,796 | | | | $ | 2,266,272 | | $ | (1,826,364) | | $ | 439,908 | | |
Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.
During the years ended December 31, 2021 and 2020, we capitalized $299,253 and $266,365 respectively of software development. We recorded amortization expense for software development costs of $391,365 and $518,087, respectively which is included in depreciation and amortization in the consolidated statement of operations.
During the years ended December 31, 2021 and 2020, we recorded impairment charges of $0 and $8,886, respectively related to our software development costs.
The estimated future amortization expense of software development costs as of December 31, 2021 is as follows:
| | |
| | |
Year ending December 31, | Amount |
2022 | | 255,501 |
2023 | | 92,288 |
2024 | | 8 |
2025 | | — |
2025 | | — |
Thereafter | | — |
Total | $ | 347,797 |
6. Operating Lease Assets
Adoption of Accounting Standards Codification (“ASC”) Topic 842, “Leases." The Company adopted Topic 842 on January 1, 2019, using the modified retrospective method and the optional transition method to record the adoption impact through a cumulative adjustment to equity. Results for reporting periods beginning after January 1, 2019, are presented under Topic 842, while prior periods are not adjusted and continue to be reported under the accounting standards in effect for those periods.
The following are additional details related to leases recorded on our balance sheet as of December 31, 2020:
| | | | |
| | | | |
Leases | Classification | | Balance at December 31, 2021 |
Assets | | | | |
Current | | | | |
Operating lease assets | Operating lease assets | | $ | — |
Noncurrent | | | | |
Operating lease assets | Noncurrent operating lease assets | | | 1,187,537 |
Total lease assets | | | $ | 1,187,537 |
| | | | |
Liabilities | | | | |
Current | | | | |
Operating lease liabilities | Operating lease liabilities | | $ | 229,240 |
Noncurrent | | | | |
Operating lease liabilities | Noncurrent operating lease liabilities | | $ | 1,188,589 |
Total lease liabilities | | | $ | 1,417,829 |
During the year ended December 31, 2021, we recorded amortization expense of $106,302 and during the year ended December 31, 2020, we recorded a credit to amortization expense of $17,214 related to the accretion of the lease liability, which is included in depreciation and amortization in the consolidated statement of operations.
Rent expense was $258,368 and $317,774 for the years ended December 31, 2021 and 2020, respectively.
We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first twelve months of the lease includes a 50% abatement period. An operating lease asset and liability will be recorded when the lease commences in accordance with ASC 842.
The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate:
| | |
| | |
Year ending December 31, | Amount |
2022 | $ | 318,055 |
2023 | | 324,220 |
2024 | | 330,894 |
2025 | | 337,567 |
2026 | | 344,241 |
Thereafter | | 28,735 |
Total future lease payments | | 1,683,712 |
Less: imputed interest | | (265,883) |
Total | $ | 1,417,829 |
| | |
| | |
Weighted Average Remaining Lease Term (years) | | |
Operating leases | | 6.00 |
| | |
Weighted Average Discount Rate | | |
Operating leases | | 6.75% |
7. Notes Payable and Interest Expense
Notes Payable
The following table presents details of our notes payable as of December 31, 2021 and 2020:
| | | | | | | | | | |
| | | | | | | | | | |
Facility | | Maturity | | Interest Rate | | Balance at December 31, 2021 | | Balance at December 31, 2020 |
BDC Term Loan | | October 15, 2021 | | 23.5% | | $ | — | | $ | 160,088 |
ACOA Note | | February 1, 2024 | | — | | | 76,642 | | | 111,430 |
Wintrust Bank | | November 1, 2021 | | Prime + 1.5% | | | — | | | 366,666 |
TD Bank | | December 31, 2022 | | — | | | 31,496 | | | 31,390 |
Chase Bank | | April 10, 2022 | | 1% | | | — | | | 891,103 |
Related Party Notes | | various | | 15% | | | 3,318,242 | | | 580,000 |
Total Debt | | | | | | | 3,426,380 | | | 2,140,677 |
Less current portion | | | | | | | (888,583) | | | (641,676) |
Long-term debt, net of current portion | | | | | | $ | 2,537,797 | | $ | 1,499,001 |
Principal payments on notes payables are due as follows:
| | |
| | |
Year ending December 31, | Amount |
2022 | $ | 1,106,676 |
2023 | | 1,808,523 |
2024 | | 447,231 |
2025 | | 63,950 |
2026 | | — |
Thereafter | | — |
Total future debt payments | | 3,426,380 |
BDC Term Loan
On January 8, 2016, Livelenz, a wholly-owned subsidiary of the Company (“Livelenz”), entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan would have matured, and the commitments would have terminated on September 15, 2019.
On July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on October 15, 2021. In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in the amount of $8,500 CAD in addition to the monthly payment of accrued interest at 23.5%. These payments increased to $10,000 CAD on November 15, 2019, $12,000 CAD on May 15, 2020, and will increase to $14,000 CAD on March 15, 2021with the final payments of $16,000 CAD on September 15, 2021.
During year ended December 31, 2021 the BDC loan was repaid in full with the final payment $80,000 CAD on October 15, 2021 in addition to the monthly interest. During the twelve months ended December 31, 2020 we repaid $88,000 CAD of principal.
ACOA Note
On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature without interest and repayments began on June 1, 2016, while the commitments will terminate on February 1, 2024. The monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1, 2019, and will increase to $4,000 CAD on August 1, 2021, $4,500 CAD on August 1, 2022 and $2,215 CAD during the remaining term of the agreement. During the twelve months ended December 31, 2020, we repaid $10,485 CAD of principal. Nine months of payments were voluntarily deferred by ACOA due to COVID-19.
During the twelve months ended December 31, 2021 $45,052 CAD in principle was paid toward the ACOA loan.
Wintrust Loan
On November 14, 2018, we entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $1,000,000. Interest accrues on the unpaid principal amount at the rate of prime plus 1.5%. The loan is a three-year loan and was interest-only payable for the first six months of the loan. Commencing on May 1, 2019, we made monthly payments of principal in the amount of $33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We used the proceeds of the loan to re-finance a loan in the principal amount of $1,000,000 we assumed as part of the acquisition of the Belly assets.
On August 7, 2020, the Company entered into an amendment of their original loan agreement dated November 14, 2018 with Wintrust Bank. Under this agreement, the covenant calculation was amended to calculate covenants under a borrowing base methodology. The Company had defaulted under the March 31, 2020 and June 30, 2020 covenants, which were waived upon execution of the amendment and there were no defaults after the amendment. During the twelve months ended December 31, 2020, we repaid $400,000 of principal. The loan was paid in full on June 30, 2021.
Chase Loan
On April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program, in the principal aggregate amount of $891,103, which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent (1%) per annum. The note contains a deferral period of six months, for which no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements. The entire loan was forgiven on July 21, 2021, at which time the company recorded a gain on extinguishment of debt in the amount of $891,103.
TD Bank Loan
On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022. This note bears interest on the unpaid balance at the rate of zero percent (0%) per annum during the initial term. Under this note no interest or principal payments are due until December 31, 2022. Under the conditions of the loan, twenty-five percent (25%) of the loan will be forgiven if seventy-five percent (75%) is repaid prior to the initial term date.
Related Party Notes
During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than December 1, 2018. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. During 2019, we repaid $1,000,000 and had $80,000 as a remaining balance of these Notes plus accrued interest. As of December 31, 2021 the balance is $0.
During the year ended December 31, 2019 we issued unsecured Notes in the principle aggregate amount of $3,500,000, which become due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty.
On July 2, 2019, $2,500,000 of this Note and the accrued interest of $82,916 was settled into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019. As of December 31, 2019, we had a principal balance of $1,080,000 as a remaining balance of these Notes plus accrued interest.
On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.
On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.
During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021.
On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than July 1, 2023. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement.
During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021.
Interest Expense
The following table summarizes interest expense for the years ended December 31, 2021 and 2020:
| | | | | |
| | | | | |
| December 31, |
| 2021 | | 2020 |
Interest expense | $ | 267,966 | | $ | 286,896 |
Total interest expense | $ | 267,966 | | $ | 286,896 |
8. Common Stock and Equity Payable
Common Stock
2020
On March 2, 2020, the Company issued 234,500 shares of common stock in exchange for cash in conjunction with a warrant exercise. The shares were exercised at the strike price of $1.00 per share.
On September 17, 2020, the Company issued 15,000 shares of common stock in exchange for cash in conjunction with a stock option exercise. The shares were exercised at the strike price of $0.48 per share.
In December of 2020, the Company commenced a private placement of its common stock with warrant exercises for one unit of our common stock at an exercise price of $1.25 per share to receive a new warrant to purchase to one share of our common stock at an exercise price of $2.00 per share. As of December 31, 2020, the Company had sold 2,666,459 units of its common stock for gross proceeds of $3,333,074. In addition, the Company issued 1,113,767 units of its common stock associated with the settlement of $1,200,000 of principal, $192,208 of accrued interest, and a loss on settlement of $668,260 (See Note 6).
On December 31, 2021, the Company recorded stock-based compensation expense of $260,003 related to restricted stock units for members of our board of directors.
As of December 31, 2020 we had an equity payable balance of $100,862.
2021
During the year ended December 31, 2021, the Company did not issue any shares but, recorded stock-based compensation expense of $260,005 related to restricted stock units for members of our board of directors. The company recorded stock-based compensation expense of $187,501 related to restricted stock units for employee compensation.
9. Stock-based Plans and Stock-based Compensation
Stock-based Plans
We have the 2010 Incentive Stock Option Plan and the 2013 Incentive Stock Option Plan under which we have granted stock options to our directors, officers and employees. As of December 31, 2021, 6,246,466 shares were authorized under the plans and 30,263,320 shares were available for future grant.
We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four years of continuous service and have 10-year contractual terms.
The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020:
| | | | | | | | | | | |
| | | | | | | | | | | |
| Shares | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value |
Outstanding at December 31, 2019 | | 5,781,884 | | $ | 1.15 | | | 7.16 | | $ | 527,868 |
Granted | | 1,545,000 | | $ | 1.19 | | | — | | $ | — |
Exercised | | (15,000) | | $ | 0.48 | | | — | | $ | — |
Forfeit/canceled | | (814,068) | | $ | 0.94 | | | — | | $ | — |
Expired | | (490,264) | | $ | 1.07 | | | — | | $ | — |
Outstanding at December 31, 2020 | | 6,007,552 | | $ | 1.20 | | | 6.77 | | $ | 4,056,639 |
Granted | | 637,500 | | $ | 1.56 | | | — | | $ | — |
Exercised | | — | | $ | 1.61 | | | — | | $ | — |
Forfeit/canceled | | (272,029) | | $ | 2.18 | | | — | | $ | — |
Expired | | (126,557) | | $ | 1.17 | | | — | | $ | — |
Outstanding at December 31, 2021 | | 6,246,466 | | $ | 1.20 | | | 7.17 | | $ | 2,500,847 |
| | | | | | | | | | | |
Expected to vest at December 31, 2021 | | 6,246,466 | | $ | 1.20 | | | 6.14 | | $ | 4,056,639 |
Exercisable at December 31, 2021 | | 4,063,765 | | $ | 1.17 | | | 4.84 | | $ | 2,252,766 |
Unrecognized expense at December 31, 2021 | $ | 1,527,647 | | | | | | | | | |
The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 2021, options to purchase 1,692,332 shares of common stock were in-the-money.
The weighted average grant-date fair value of options granted during the years 2021 and 2020 was $0.99 and $0.79, respectively.
2020
On March 24, 2020, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the closing price as of March 24, 2020 of $0.65 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 24, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.56% and an option fair value of $0.43 was $6,472.
On April 6, 2020, the Company granted four employees a total of 700,000 options to purchase shares of the Company common stock at the closing price as of April 6, 2020 of $0.70 per share. 500,000 option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until April 6, 2030. 200,000 option shares will vest ratably over forty-eight (48) months and are exercisable until April 6, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.21% and an option fair value of $0.47 was $326,752.
On November 5, 2020, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of November 5, 2020 of $0.96 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 5, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.36% and an option fair value of $0.63 was $12,689.
On December 7, 2020, the Company granted one employee a total of 600,000 options to purchase shares of the Company common stock at the closing price as of December 7, 2020 of $1.55 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 7, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.35% and an option fair value of $1.03 was $615,495.
On December 17, 2020, the Company granted six employees a total of 210,000 options to purchase shares of the Company common stock at the closing price as of December 17, 2020 of $1.83 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 17, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.41% and an option fair value of $1.21 was $254,373.
2021
On March 26, 2021, the Company granted five employee a total of 67,500 options to purchase shares of the Company common stock at the closing price as of March 26, 2021, of $1.80 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until March 26, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97% and an option fair value of $1.16 was $78,492.
On May 17, 2021, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of May 17, 2021, of $1.67 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until January 21, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79% and an option fair value of $0.93 was $18,628.
On August 11, 2021, the Company granted one employee a total of 5,000 options to purchase shares of the Company common stock at the closing price as of August 11, 2021, of $1.53 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until August 11, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.29% and an option fair value of $1.12 was $5,606.
On December 15, 2021, the Company granted nineteen employees a total of 545,000 options to purchase shares of the Company common stock at the closing price as of December 15, 2021, of $1.53 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until February 18, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 71.53% and an option fair value of $.97 was $528,434.
Stock-based Compensation Expense
The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2021 and 2020 was as follows:
| | | | | |
| | | | | |
| Years Ended |
| December 31, |
| 2021 | | 2020 |
General and administrative | $ | 289,782 | | $ | 267,306 |
Sales and marketing | | 81,093 | | | 75,235 |
Engineering, research, and development | | 178,893 | | | 171,394 |
| $ | 549,768 | | $ | 513,935 |
As of December 31, 2021, there was approximately $1,527,647 of unearned stock-based compensation that will be expensed from 2022 through 2026. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel all or a portion of the remaining unearned stock-based compensation expense. Future unearned stock-based compensation will increase to the extent we grant additional equity awards.
Stock Option Valuation Assumptions
We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2021 and 2020:
| | | | |
| | | | |
| | Years Ended |
| | December 31, |
| | 2021 | | 2020 |
Risk-free interest rate | | 0.42% to 0.58% | | 0.42% to 0.58% |
Expected life (years) | | 6.00 | | 6.00 |
Expected dividend yield | | — | | — |
Expected volatility | | 59.90% to 80.26% | | 77.36% to 78.21% |
The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.
The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards.
The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.
The expected volatility in 2021 and 2020 is based on the historical publicly traded price of our common stock.
Restricted stock units
The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2021 and 2020:
| | | | | | | | | | | |
| | | | | | | | | | | |
| Shares | | Weighted Average Grant Date Fair Value | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value |
Outstanding at December 31, 2019 | | 1,152,248 | | $ | 0.86 | | | — | | $ | 1,120,404 |
Awarded | | 284,480 | | $ | 0.91 | | | — | | $ | 60,003 |
Released | | — | | $ | — | | | — | | $ | — |
Canceled/forfeited/expired | | — | | $ | — | | | — | | $ | — |
Outstanding at December 31, 2020 | | 1,436,728 | | $ | 0.86 | | | — | | $ | 1,180,407 |
Awarded | | 654,663 | | $ | 1.77 | | | — | | $ | 260,005 |
Released | | — | | $ | — | | | — | | $ | — |
Canceled/forfeited/expired | | (406,250) | | $ | 2 | | | — | | $ | (192,339) |
Outstanding at December 31, 2021 | | 1,685,141 | | $ | 1.18 | | | — | | $ | 1,248,073 |
| | | | | | | | | | | |
Vested at December 31, 2021 | | 1,685,141 | | $ | — | | | — | | $ | 2,595,117 |
Unvested at December 31, 2021 | | — | | $ | — | | | — | | $ | — |
Unrecognized expense at December 31, 2021 | $ | — | | | | | | | | | |
2020
On March 24, 2020, the Company issued to four independent directors a total of 100,000 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2020. The units were valued at $65,000 or $0.65 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 24, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On August 7, 2020, the Company granted four independent directors a total of 81,252 restricted stock units. The units were valued at $65,000 or $0.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 7, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On November 5, 2020, the Company granted four independent directors a total of 67,708 restricted stock units. The units were valued at $65,000 or $0.96 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) November 5, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On December 17, 2020, the Company granted four independent directors a total of 35,520 restricted stock units. The units were valued at $65,000 or $1.83 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 17, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
In the twelve months ended December 31, 2020, the company recorded $260,003 respectively, in restricted stock units as board compensation.
2021
On March 26, 2021 an employee was granted 500,000 restricted stock units. These restricted stock units were issued as compensation The units were valued at $900,000 or $1.80 per share, based on the closing stock price on the date of grant. units vested 1/48th monthly for four years. The total units vested in 2021 were 114,583.
On March 26, 2021 the Company issued to four independent directors a total of 36,112 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2021. The units were valued at $65,000 or $1.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 26, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On May 12, 2021, the Company granted four independent directors a total of 38,924 restricted stock units. The units were valued at $65,000 or $1.67 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) May 12, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On August 11, 2021, the Company granted four independent directors a total of 37,144 restricted stock units. The units were valued at $65,000 or $1.75 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 11, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
On December 15, 2021, the Company granted four independent directors a total of 42,484 restricted stock units. The units were valued at $65,000 or $1.53 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.
In the twelve months ended December 31, 2021, the company recorded $447,506 in restricted stock units as board compensation.
Restricted Stock Unit Compensation Expense
The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2021 and 2020 was as follows:
| | | | | |
| | | | | |
| Years Ended |
| December 31, |
| 2021 | | 2020 |
General and administrative | $ | 260,005 | | $ | 260,003 |
Sales and Marketing | | 187,501 | | | — |
| $ | 447,506 | | $ | 260,003 |
10. Warrants to Purchase Common Stock
The following table summarizes investor warrant activity as of and for the years ended December 31, 2021 and 2020:
| | | | | | | | |
| | | | | | | | |
| Shares | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) |
Outstanding at December 31, 2019 | | 3,358,459 | | $ | 1.23 | | | 1.27 |
Granted | | 2,666,459 | | $ | — | | | — |
Exercised | | (2,900,959) | | $ | — | | | — |
Canceled/forfeited/expired | | (432,500) | | $ | — | | | — |
Outstanding at December 31, 2020 | | 2,691,459 | | $ | 1.99 | | | 2.94 |
Granted | | 580,231 | | $ | — | | | — |
Exercised | | — | | $ | — | | | — |
Canceled/forfeited/expired | | (25,000) | | $ | — | | | — |
Outstanding at December 31, 2021 | | 3,246,690 | | $ | 2.26 | | | 3.59 |
We did not record any stock-based compensation expense for the years ended December 31, 2021 and 2020, respectively in connection with the exercise of investor-based warrants.
Warrants Exercised in 2020
During year ending December 31, 2021 no warrants were exercized.
11. Income Taxes
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the 2017 Act). The changes are mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits. The Company does not anticipate the application of the CARES Act provisions to materially impact the overall Consolidated Financial Statements.
For the years ended December 31, 2021 and 2020 the provisions for income taxes were as follows:
| | | | | |
| 2021 | | 2020 |
Federal – current | $ | — | | $ | — |
State – current | | — | | | — |
Foreign – current | | — | | | — |
Total | $ | — | | $ | — |
Under ASC 740, deferred income tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Significant components of our net deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows:
| | | | | |
| 2021 | | 2020 |
Deferred tax assets (liabilities): | | | | | |
Net operating loss carryforwards | $ | 16,915,000 | | $ | 14,881,000 |
Stock based compensation | | 4,372,000 | | | 4,094,000 |
Accrued compensation | | 31,000 | | | 19,000 |
Depreciation and amortization | | 3,783,000 | | | 3,867,000 |
Other | | 2,000 | | | — |
Total deferred tax assets | | 25,103,000 | | | 22,861,000 |
Valuation allowance for net deferred tax assets | | (25,103,000) | | | (22,861,000) |
Total | $ | — | | $ | — |
The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 2021 and 2020 due to uncertainties regarding the realization of such assets.
The net change in the total valuation allowance for the year ended December 31, 2021 was an increase of approximately $2,479,000. The net change in the total valuation allowance for the year ended December 31, 2020 was an increase of approximately $568,000. In assessing the valuation of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. The Company considers projected future taxable income and planning strategies in making this assessment. Based on the level of historical operating results and projections for the taxable income for the future, the Company has determined that it is more likely than not that the deferred tax assets will not be realized. Accordingly, the Company has recorded a valuation allowance to reduce deferred tax assets to zero. There can be no assurance that the Company will ever be able to realize the benefit of some or all of the federal and state loss carryforwards, either due to ongoing operating losses orf due to ownership changes, which limit the usefulness of the loss carryforwards.
As of December 31, 2021, the Company has available net operating loss carryforwards of approximately $64,000,000 for federal income tax purposes, which will start to expire in 2026. The net operating loss carryforwards for state purposes are approximately $61,000,000 and will start to expire in 2028.
The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2021 and 2020 was as follows:
| | | | | |
| 2021 | | 2020 |
Computed expected tax expense | $ | (1,735,000) | | $ | (613,000) |
State taxes, net of federal benefit | | (799,000) | | | (141,000) |
Expiration of NOL carryforwards | | 87,000 | | | 44,000 |
Other | | (32,000) | | | 142,000 |
Change in valuation allowance | | 2,479,000 | | | 568,000 |
Total | $ | — | | $ | — |
The Company has determined that during 2010 it experienced a “change of ownership” as defined by Section 382 of the Internal Revenue Code. As such, utilization of net operating loss carryforwards and credits generated before the 2010 change in ownership will be limited to approximately $207,000 per year until such carryforwards are fully utilized. The pre change net operating loss carryforward was approximately $6,000,000. Since 2010 the Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since 2010, utilization of the net operating loss carryforwards tax credit carryforwards would be subject to further annual limitation under Section 382. Any limitation may result in expiration of a portion of the net operating loss carryforwards before utilization.
The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006, the Company is subject to U.S. federal and state income tax examinations by tax authorities for all years since 2006. The Company does not have a liability for any uncertain tax positions. As of December 31, 2021, no accrued interest or penalties are recorded in the financial statements.
12. Fair Value Measurements of Financial Instruments
The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021:
| | | | | | | | | | | |
| | | | | | | | | | | |
Description | Level 1 | | Level 2 | | Level 3 | | Gains (Losses) |
Goodwill (non-recurring) | $ | — | | $ | — | | $ | 411,183 | | $ | — |
Intangibles, net (non-recurring) | $ | — | | $ | — | | $ | 1,124,720 | | $ | — |
The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020:
| | | | | | | | | | | |
| | | | | | | | | | | |
Description | Level 1 | | Level 2 | | Level 3 | | Gains (Losses) |
Goodwill (non-recurring) | $ | — | | $ | — | | $ | 496,352 | | $ | — |
Intangibles, net (non-recurring) | $ | — | | $ | — | | $ | 1,368,329 | | $ | — |
The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 valuation techniques.
The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.
13. Commitments and Contingencies
Litigation
As of the date of this report, the company has one pending legal proceeding related to TCPA (Telephone Consumer Protection Act) Violation. We are currently in the process of settling with the claimant.
Operating Lease
As described in Note 6, the Company had a lease through January 2021 for 10,395 square feet of office space located at 55 N. Arizona Ave., Suite 310, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, are $20,140. As of December 31, 2021, we have an operating lease asset balance for this lease of $0 and an operating lease liability balance for this lease of $0 recorded in accordance with ASC 842.
We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first twelve months of the lease included a 50% abatement period. As of December 31, 2021, we have an operating lease asset balance for this lease of $1,177,094 and an operating lease liability balance for this lease of $1,404,533 recorded in accordance with ASC 842.
The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $3,371 per month, excluding common area maintenance charges. As of December 31, 2021, we have an operating lease asset balance for this lease of $10,443 and an operating lease liability balance for this lease of $13,296 recorded in accordance with ASC 842.
14. Employee Benefit Plan
The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. Participants in the Plan may contribute a percentage of compensation, but not in excess of the maximum allowed under the Code. The Company may make contributions at the discretion of its Board of Directors. During the years ended December 31, 2021 and 2020, the Company made no contributions to the Plan.
15. Related Party Transactions
Unsecured Promissory Note Investments in 2019
During the year ended December 31, 2018, we commenced an offer to certain investors, officers and directors of the Company Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”). In 2019, we issued to one of our directors, unsecured Notes in the principal aggregate amount of $3,500,000, which are due and payable two years after issuance. These notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. We conducted the private placement of our securities in July 2019. The Note holder participated in the private placement by settling principal of $2,500,000 and accrued interest under the notes totaling $82,916, for 2,582,916 units of our securities. The remaining 2019 Notes for $1,000,000 aggregated principal were settled with the December of 2020 private placement. As of December 31, 2020, we have $80,000 as a remaining balance of these Notes and accrued interest of $33,533.
Unsecured Promissory Note Investments in 2020
On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.
On January 25, 2021, we repaid $65,000 for an unsecured Note. On January 27, 2021, we repaid the remaining $15,000 of the unsecured Note and accrued interest of $34,379.
Unsecured Promissory Note Investments in 2021
On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than July 1, 2023. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement.
Secured Promissory Note Investment in 2021
On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.
During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021.
16. Subsequent Events
2022 Warrants Exercise
On February 7, 2022 seventeen warrant holders exercised their common stock purchase warrant for 3,163,190 shares at the exercise price of $.80 per share, resulting in additional capital of $2,530,552. As an inducement for the holder’s exercise of the warrants, we issued the holders 2,530,552 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's (“SEC”) rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management to allow timely decisions regarding required disclosure.
As required by paragraph (b) of Rules 13a-15 or 15d-15 under the Exchange Act, our management, with the participation of our president (our principal executive officer) and our chief financial officer (our principal financial officer and principal accounting officer) evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this annual report, being December 31, 2021 (the "Evaluation Date"). Based on such evaluation and subject to the foregoing, such officers have concluded that, as of the Evaluation Date, the Company's disclosure controls and procedures are not effective at the reasonable assurance level to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. The term “internal control over financial reporting” is defined as a process designed by, or under the supervision of, an issuer’s principal executive and principal financial officers, or persons performing similar functions, and effected by the issuer’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
(1)pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer; and
(2)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer.
Under the supervision of our Chief Executive Officer, being our principal executive officer, and our Chief Financial Officer, being our principal financial officer and principal accounting officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021 using the criteria established in Internal Control—2013 Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation. Based on this evaluation under the criteria established in Internal Control – Integrated Framework, our management concluded that our internal control over financial reporting was not effective as of December 31, 2021.
This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report is not subject to attestation by our registered, public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.
Changes in Internal Control
There was no change in our internal control over financial reporting, as defined in Rules 13a-15(f)under the Exchange Act, that occurred during the fiscal year ended December 31, 2021 and 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.
PART III
Item 10. Directors and Executive Officers
Directors and Executive Officers
The following table sets forth information concerning our executive officers and directors, including their ages, as of March 20, 2022:
| | | | |
Name | | Age | | Position |
Dennis Becker | | 47 | | Chief Executive Officer and Chairman of the Board |
Lisa Brennan | | 55 | | Chief Financial Officer |
John Harris | | 72 | | Lead Director and Chairman of Compensation Committee |
Philip Guarascio | | 79 | | Chairman of Governance and Nominating Committee and Director |
Doug Schneider | | 58 | | Director |
Tom Akin | | 68 | | Chairman of Audit Committee and Director |
Dennis Becker - Chief Executive Officer, Executive Chairman and Director
Dennis Becker was appointed our Chief Executive Officer and a Director effective as of our acquisition of Mobivity, Inc. in November 2010. Mr. Becker has also served as President and Chief Executive Officer of Mobivity, Inc. since September 2007. Our board of directors appointed Mr. Becker as Chairman of the Board of Directors effective as of March 31, 2017. Mr. Becker was a founder of Frontieric Corporation, a pioneer in providing complex call routing and merchant processing applications, where he was Chief Executive Officer from 2002 to 2005. Mr. Becker was also Chief Executive Officer of Bexel Technologies, which served solutions to large enterprises, from 1999 to 2001. Mr. Becker studied Computer Science at the University of Oregon and served in the United States Air Force.
Mr. Becker has extensive knowledge of the mobile message marketing industry. As a result of these and other professional qualifications, we have concluded that Mr. Becker is qualified to serve as a director.
Lisa Brennan - Chief Financial Officer
On December 7, 2020, the board of directors of the Company appointed Lisa Brennan to serve as Chief Financial Officer of the Company. Ms. Brennan has over 25 years of executive financial management experience with both public and private companies. Ms. Brennan was most recently the CFO of Network Group, LLC, a co-working company. Previously, Ms. Brennan was the CFO and VP Financial Planning at Merchant Customer Exchange “MCX”, a mobile payment technology business, culminating in the company’s acquisition by JPMorgan Chase. Ms. Brennan holds a BA, Summa Cum Laude, in Mathematics and Economics from Wellesley College, MS in mathematics from Brandeis University, and an MBA from the Massachusetts Institute of Technology Sloan School of Business.
Ms. Brennan is the daughter of Philip Guarascio, a member of our Board of Directors. Ms. Brennan has extensive knowledge of Generally Accepted Accounting Principles and preparation of financial statements for a publicly traded company. As a result of these and other professional qualifications, we have concluded that Ms. Brennan is qualified to serve as an officer.
John Harris – Non-Executive Chairman and Chairman of Compensation Committee
Mr. Harris has been a director since January 2011. Mr. Harris has served as an operating partner with Glendon Todd Capital, a Dallas based private equity firm from February 2011 to February 2015. From 2010 to 2012 Mr. Harris was CEO and investor with Chemical Information Services, a leading provider of database services to the chemical and pharmaceutical industries. From 2006 to 2009, Mr. Harris was President and CEO of eTelecare Global Solutions; a business process outsourcing (“BPO”) company delivering technical support, sales, and customer care services to the Fortune 1000 market. In that capacity, he successfully led the company’s IPO, privatization and ultimate merger in 2009 that created a $1 billion BPO services company. Previously, Mr. Harris served in various executive level positions with Electronic Data Systems over a 25-year period. Mr. Harris graduated from the University of West Georgia with a BBA and MBA and is on the Board of Advisors to the Richardson School of Business. He has held board positions with a number of public and private telecommunications and technology services companies, and he currently sits on the board of The Hackett Group and is the head of their compensation committee.
Mr. Harris has extensive knowledge of corporate management. As a result of these and other professional qualifications, we have concluded that Mr. Harris is qualified to serve as a director.
Philip Guarascio - Chairman of Governance and Nominating Committee and Director
Mr. Guarascio has served as a director since March 2014. Mr. Guarascio has been the Chairman and Chief Executive Officer of PG Ventures LLC since May 2000 where he serves as a marketing and advertising business consultant. He was Lead Executive, Marketing and Sales at the National Football League from 2003-2007 and has been a consultant for the William Morris Agency since October 2001. For 16 years, Mr. Guarascio was with General Motors where he served as Vice President of Corporate Advertising and Marketing primarily responsible for worldwide advertising resource management, managing consolidated media placement and before that as General Manager of Marketing and Advertising for General Motors' North American Operations. Mr. Guarascio introduced the GM Card and managed the General Motors corporate brand to a 20 percent increase in customer purchase consideration. He joined General Motors in 1985 after 21 years with the New York advertising agency, D'Arcy, Masius, Benton & Bowles.
Mr. Guarascio has extensive experience in the marketing and advertising industry. Based on this and other professional qualifications, we have concluded that Mr. Guarascio is qualified to serve as a director.
Doug Schneider - Director
Mr. Schneider has been a director since December 2010. Mr. Schneider has a twenty-year track record of leadership and success in launching, building, and managing high-tech service-oriented companies. He has served as Executive Vice President of the SMB Solutions for the Melbourne IT Group since July 2012 and oversees a $75MM per year hosting and domain registration business across North American and Asia Pacific. From 2011 to 2012, Mr. Schneider served as CEO for Transaction Wireless, a venture backed technology company where he still resides on the board. From 2007 to 2010, Mr. Schneider was the CEO of Genea Energy, a clean tech company that provides an innovative and comprehensive SaaS based energy services platform for commercial office building portfolios. Mr. Schneider received a Bachelor's degree in Mechanical Engineering from University of California, Davis and an M.B.A. from the Kellogg School of Management at Northwestern University. He also serves as an industry advisor to Pelion Venture Partners, a venture capital firm focused on the information technology sector.
Mr. Schneider has extensive knowledge of corporate management. As a result of these and other professional qualifications, we have concluded that Mr. Schneider is qualified to serve as a director.
Thomas Akin – Chairman of the Audit Committee and Director
Mr. Akin has been a director since March 2015. Mr. Akin has been the Managing General Partner of Talkot Partners I, Talkot Partners II, LLC, Talkot Crossover Fund, LP, and Talkot Capital LLC since 1996 and was appointed as a director in March 2015. Mr. Akin served as the Chief Executive Officer of Dynex Capital Inc, from February 2008 to 2013. Mr. Akin had been with Merrill Lynch and Co., including served as its Managing Director of the Western United States for Merrill Lynch Institutional Services from 1991 to 1994 and as Regional Director of the San Francisco and Los Angeles regions for Merrill Lynch Institutional Services from 1981 to 1991. Mr. Akin had been with Salomon Brothers from 1978 to 1981. He has been an Executive Chairman of Dynex Capital Inc. since January 2014 and has been its the Chairman since May 30, 2003. He served as the Chairman of Infotec since 2001. Mr. Akin has been a Director of Acacia Technologies Group of Acacia Research Corp. since May 1998, Dynex Capital Inc, since May 2003, Acacia Research Corp. since May 1998 and eFax.com, Inc. since July 1996. He serves as a Director of ADX. He served as a Director CombiMatrix Corporation since May 1998. Mr. Akin holds a B.A. in Biology from the University of California at Santa Cruz and an M.B.A. from the University of California at Los Angeles.
Because Mr. Akin has extensive experience as a professional investor and public company director, we have concluded that Mr. Akin is qualified to serve as a director.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our directors and executive officers, and persons who beneficially own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes of ownership of common stock and our other equity securities. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.
To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December 31, 2021, our officers, directors and greater than ten percent beneficial owners complied with all Section 16(a) filing requirements applicable to them.
Additional Information about our Board and its Committees
All of our directors except Mr. Becker are considered by our board of directors to be “independent” as defined in Rule 5605(a)(2) of the NASDAQ Marketplace Rules.
Audit Committee
During the year ended December 31, 2021, our audit committee was comprised of Thomas Akin, John Harris, and Doug Schneider. Our board of directors has appointed Mr. Akin to serve as chairman of the audit committee effective as of April 1, 2017.
All members of our audit committee are independent, as independence is defined in Rule 5605(a)(2) of the NASDAQ Marketplace Rules.
Compensation Committee
During the year ended December 31, 2021, our compensation committee was comprised of John Harris, Phil Guarscio and Tom Akin. Mr. Harris currently serves as compensation committee chair.
Governance and Nominating Committee
During the year ended December 31, 2021, our governance and nominating committee was comprised of Phil Guarscio, John Harris and Thomas Akin. Mr. Guarascio currently serves as governance and nominating committee chair.
Committee Interlocks and Insider Participation
None of our executive officers serve on the board of directors of another entity, whose executive officers serves on our board of directors.
Code of Ethics
We have adopted a code of ethics for all our employees, including our chief executive officer, principal financial officer and principal accounting officer or controller, and/or persons performing similar functions, which is available on our website, under the link entitled “Code of Ethics”.
Item 11. Executive Compensation
The following table summarizes the total compensation earned by our Chief Executive Officer and our other two most highly paid executive officers for the years ended December 31, 2021 and 2020. In reviewing the table, please note that:
Lynn Tiscareno served as our Chief Financial Officer from August 2019 to December 6, 2020; and
Lisa Brennan has served as our Chief Financial Officer since December 7, 2020.
Summary Compensation Table*
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Name and Principal Position | | Year | | Salary | | Bonus | | Stock Awards (1) | | Option Awards (1) | All Other Compensation | | Total |
Dennis Becker, Chairman & CEO | | 2020 | | $ | 310,000 | | $ | 65,000 | | $ | — | | $ | — | $ | — | | $ | 375,000 |
| | 2020 | | $ | 296,646 | | $ | — | | $ | — | | $ | — | $ | — | | $ | 296,646 |
Lisa Brennan, CFO | | 2021 | | $ | 225,000 | | $ | — | | $ | — | | $ | — | $ | — | | $ | 225,000 |
| | 2020 | | $ | 12,981 | | $ | — | | $ | — | | $ | 615,495 | $ | — | | $ | 628,476 |
Lynn Tiscareno, former CFO | | 2021 | | $ | 923 | | $ | 15,000 | | $ | — | | $ | — | $ | — | | $ | 15,923 |
| | 2020 | | $ | 177,877 | | $ | — | | $ | — | | $ | 95,358 | $ | — | | $ | 273,235 |
* In accordance with the rules and regulations promulgated by the Securities and Exchange Commission, the table omits columns that are not applicable.
(1)The value of the stock and stock option compensation was computed using the Black-Scholes Option Pricing Model and represents the aggregate grant date fair value computed in accordance with ASC Topic 718. For information on the method and assumptions used to calculate the compensation costs, see Note 9 to our audited consolidated financial statements contained herein.
The following table presents the outstanding option awards held by each of our named executive officers as of December 31, 2020, including the value of the options awards.
Outstanding Equity Awards at December 31, 2021*
| | | | | | | | | | | |
| | | | | | | | | | | |
Name | | Number of Securities Underlying Unexercised Options (#) Exercisable | | Equity Incentive Plan Awards; Number of Securities Underlying Unexercised Unearned Options (#) Unexercisable | | Option Exercise Price | | Option Expiration Date |
Dennis Becker, CEO & Chairman | | | 100,000 | | | — | | $ | 1.28 | | 1/22/2025 |
Dennis Becker, CEO & Chairman | | | 1,251,978 | | | — | | $ | 1.80 | | 6/17/2023 |
Dennis Becker, CEO & Chairman | | | 1,000,000 | | | — | | $ | 0.60 | | 5/15/2027 |
Dennis Becker, CEO & Chairman | | | 500,000 | | | 500,000 | | $ | 1.04 | | 5/17/2029 |
Lisa Brennan, CFO | | | 450,000 | | | 150,000 | | $ | 1.55 | | 12/7/2030 |
* In accordance with the rules and regulations promulgated by the Securities and Exchange Commission, the table omits columns that are not applicable.
Employment Agreements
Dennis Becker
On January 11, 2011, we entered into an employment agreement with Dennis Becker. Under the terms of the agreement, Mr. Becker will serve as our President and Chief Executive Officer for an initial term of three years from December 24, 2010 (the “Effective Date”). Unless terminated no less than 90 days prior to the expiration date by either party, the agreement is renewed automatically for successive one-year periods. Under the agreement, Mr. Becker is paid a base annual salary of $120,000. The base salary is subject to an annual increase at the sole discretion our board of directors. In addition to regular annual increases, the base salary will be increased by $30,000 (up to a cumulative maximum of $60,000) for each acquisition of the stock or all or substantially all of the assets of a third party entity, or the formation of joint ventures resulting in operating cash flows minus capital expenditures and dividends of no less than $25,000 during a three month period ending six months after the completion of each such acquisition or formation of such joint venture. In addition, his salary will be increased to $225,000 in the event we complete a financing transaction of no less than $3,000,000 and we complete one acquisition. The board may further award him, at its sole discretion, an annual bonus of up to 50% of his base salary and grant him stock options.
On June 17, 2013, the Company granted Mr. Becker an option to purchase 1,251,978 shares of Company common stock, over a ten-year period from the date of grant, at an exercise price of $1.80 per share, representing the closing price of the Company’s common stock on June 17, 2013. The options vested and first become exercisable at the rate of 1/48th per month over a 48-month period commencing on the date of grant.
Effective March 30, 2015, based on the successful results of the March 2015 capital raise, the board increased Mr. Becker’s annual base salary by $50,000 to $275,000, awarded him a bonus payment of $30,000, and also granted him options to purchase 100,000 shares of our common stock at an exercise price of $1.28 with 25% vesting after 1 year from date of grant and 1/36 per month afterwards.
Effective November 17, 2016, the board increased Mr. Becker’s annual base salary by $35,000 to $310,000 based on his annual merit review.
On May 15, 2017, the Company granted Mr. Becker an option to purchase 1,000,000 shares of Company common stock, over a ten-year period from the date of grant, at an exercise price of $0.60 per share, representing the closing price of the Company’s common stock on May 15, 2017. The options will vest and first become exercisable at the rate of 25% vesting after 1 year from date of grant and 1/36 per month afterwards.
On May 17, 2019, the Company granted Mr. Becker an option to purchase 1,000,000 shares of Company common stock, over a ten-year period from the date of grant, at an exercise price of $1.04 per share, representing the closing price of the Company’s common stock on May 17, 2019. 500,000 options vested immediately, and 500,000 options will vest and first become exercisable on May 17, 2023. Mr. Becker’s options shall otherwise be on terms and conditions contained in the Company’s current equity incentive plan.
If the agreement is terminated by us without cause (as defined in the agreement) or the we notify Mr. Becker that we will not renew the agreement, we will be required to pay him a severance payment equal to six months of his base salary payable in regular intervals following such termination or expiration of the agreement.
The agreement includes non-compete, non-solicitation, intellectual property assignment and confidentiality provisions that are customary in our industry.
Lisa Brennan
On December 7, 2020, we appointed Lisa Brennan as Chief Financial Officer. In connection with the appointment, the Company entered into an employment agreement dated December 7, 2020 with Ms. Brennan.
Pursuant to her employment agreement, the Company agreed to pay Ms. Brennan an annual base salary of $225,000, subject to annual review by the board. Ms. Brennan will be eligible for annual performance bonuses of up to 30% of her base salary for meeting key performance requirements, quotas, and assigned objectives determined annually by the board. Also pursuant to her employment agreement with the Company, Ms. Brennan is eligible to participate in all benefits, plans, and programs, including improvements or modifications of the same, which are now, or may hereafter be, available to other executive employees of Company. Ms. Brennan’s employment agreement contains standard provisions concerning noncompetition, nondisclosure, and indemnification.
Pursuant to Ms. Brennan’s employment agreement, the Company has granted Ms. Brennan an option to purchase 600,000 shares of Company common stock, over a ten-year period from the date of grant, at an exercise price of $1.55 per share, representing the closing price of the Company’s common stock on December 7, 2020. The options will vest and first become exercisable at the rate of 1/48th per month over a 48-month period commencing on the date of grant. Ms. Brennan’s options shall otherwise be on terms and conditions contained in the Company’s current equity incentive plan.
In the event Ms. Brennan’s employment with the Company is terminated by the Company without cause, the Company shall pay Ms. Brennan, in addition to all other amounts then due and payable, three (3) additional monthly installments of her base salary.
The agreement includes non-compete, non-solicitation, intellectual property assignment and confidentiality provisions that are customary in our industry.
Non-Employee Director Compensation
2021 Director Compensation Table
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
Name | | Fees Earned | | Stock Awards | | Option Awards | | Non-Equity Incentive Plan Compensation | | Deferred Compensation Earnings | | All Other Compensation | | Total |
Doug Schneider | | $ | 65,000 | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | 65,000 |
John Harris | | $ | 65,000 | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | 65,000 |
Thomas Akin | | $ | 65,000 | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | 65,000 |
Phil Guarascio | | $ | 65,000 | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | 65,000 |
The Company recorded an expense of $65,000 per director related to restricted stock units for members of our board of directors for the twelve months ended December 31, 2021.
Item 12. Security Ownership of Certain Beneficial Owners and Management
The following table sets forth as of March 19, 2021, certain information regarding the beneficial ownership of our common stock. The table sets forth the beneficial ownership of (i) each person who, to our knowledge, beneficially owns more than 5% of our outstanding shares of Common Stock; (ii) each of our directors and executive officers; and (iii) all of our executive officers and directors as a group. The number of shares owned includes all shares beneficially owned by such persons, as calculated in accordance with Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).The number of shares beneficially owned by a person includes shares of common stock underlying options or warrants held by that person that are currently exercisable or exercisable within 60 days of March 19, 2021. The shares issuable pursuant to the exercise of those options or warrants are deemed outstanding for computing the percentage ownership of the person holding those options and warrants but are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Unless otherwise indicated, the address of each shareholder is c/o the Company, 3133 W. Frye Road, Chandler, AZ 85226.
| | | | | |
| | | | | |
Name of Beneficial Owner | Shares Beneficially Owned | | Percentage of Shares Beneficially Owned (1) |
Dennis Becker (2) | | 3,043,981 | | 5 | % |
Lisa Brennan (3) | | — | | — | |
Doug Schneider (4) | | 496,805 | | 1 | % |
John Harris (5) | | 532,575 | | 1 | % |
Phil Guarascio (6) | | 444,678 | | 1 | % |
Thomas Akin (7) | | 16,190,620 | | 29 | % |
Executive Officers and Directors as a Group (six persons) | | 20,708,659 | | 37 | % |
| | | | | |
5% Beneficial Owners | | | | | |
Bruce Terker | | 6,361,082 | | 11 | % |
Cornelis F. Wit | | 3,700,141 | | 7 | % |
(1)Applicable percentage of ownership is based upon 55,410,695 shares of common stock outstanding as of March 23, 2022.
(2)Includes 2,851,978 shares of common stock issuable pursuant to presently exercisable stock options, including options that will vest within 60 days of March 19, 2021.
(3)Includes no shares of common stock issuable pursuant to presently exercisable stock options, including options that will vest within 60 days of March 19, 2021.
(4)Includes 356,490 shares of common stock issuable upon settlement of restricted stock units, including restricted stock units that will vest within 60 days of March 19, 2021. Includes 74,447 shares of common stock owned of record by The Schneider Family Trust.
(5)Includes 406,743 shares of common stock issuable upon settlement of restricted stock units, including restricted stock units that will vest within 60 days of March 19, 2021.
(6)Includes 367,681 shares of common stock issuable upon settlement of restricted stock units, including restricted stock units that will vest within 60 days of March 19, 2021.
(7)Includes 7,423,232 shares of Common Stock owned of record by Talkot Fund, L.P., 305,814 shares of common stock issuable upon settlement of restricted stock units, including restricted stock units that will vest within 60 days of March 19, 2021 and 1,541,459 of stock warrants to purchase Common Stock.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Certain Relationships and Related Transactions
During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest is due and payable no later than December 1, 2018. We may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. During 2019, we repaid $1,000,000 and had $80,000 as a remaining balance of these Notes plus accrued interest.
During the year ended December 31, 2019 we issued unsecured Notes in the principle aggregate amount of $3,500,000, which become due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay any of the Notes without notice, subject to a two percent (2%) pre-payment penalty.
On July 2, 2019, $2,500,000 of this Note and the accrued interest of $82,916 was settled into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019. As of December 31, 2019, we had a principal balance of $1,080,000 as a remaining balance of these Notes plus accrued interest.
On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000, which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, subject to a two percent (2%) pre-payment penalty.
On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on conversion of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.
On January 25, 2021, we repaid $65,000 for an unsecured Note. On January 27, 2021, we repaid the remaining $15,000 of the unsecured Note and accrued interest of $34,379.
On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $149,040. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.
During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $262,758 using the Black-Scholes option valuation model as of December 31, 2021.
The board conducts an appropriate review of and oversees all related party transactions on a continuing basis and reviews potential conflict of interest situations where appropriate. The board has not adopted formal standards to apply when it reviews, approves or ratifies any related party transaction. However, the board has followed the following standards: (i)all related party transactions must be fair and reasonable to us and on terms comparable to those reasonably expected to be agreed to with independent third parties for the same goods and/or services at the time they are authorized by the board and (ii)all related party transactions should be authorized, approved or ratified by the affirmative vote of a majority of the directors who have no interest, either directly or indirectly, in any such related party transaction.
Indemnification Agreements with Directors and Executive Officers
We have entered into indemnity agreements with certain directors, officers and other key employees of ours under which we agreed to indemnify those individuals under the circumstances and to the extent provided for in the agreements, for expenses, damages, judgments, fines, settlements and any other amounts they may be required to pay in actions, suits or proceedings which they are or may be made a party or threatened to be made a party by reason of their position as a director, officer or other agent of ours, and otherwise to the fullest extent permitted under Nevada law and our bylaws. We also have an insurance policy covering our directors and executive officers with respect to certain liabilities, including liabilities arising under the Securities Act of 1933, as amended, or otherwise. We believe that these provisions and insurance coverage are necessary to attract and retain qualified directors, officers and other key employees.
Item 14. Principal Accounting Fees and Services
The following table represents aggregate fees billed to us for the years ended December 31, 2021 and 2020 by M&K CPAs, our principal auditors for such periods. All fees described below were approved by the board of directors.
| | | | | |
| | | | | |
| 2021 | | 2020 |
Audit Fees | $ | 41,000 | | $ | 56,000 |
Audit-Related Fees | | 33,000 | | | 31,500 |
Tax Fees | | 6,000 | | | 5,574 |
All Other Fees | | — | | | — |
Total Fees | $ | 80,000 | | $ | 93,074 |
Board of Directors’ Pre-Approval Policies and Procedures
The board of directors has adopted a policy for the pre-approval of audit and non-audit services rendered by our independent auditors, M&K CPAs, who’s firm ID is 2738. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approval may also be given as part of the board’s approval of the scope of the engagement of the independent auditors or on an individual explicit case-by-case basis before the independent auditors are engaged to provide each service.
The board of directors has determined that the rendering of the services other than audit services by M&K CPAs is compatible with maintaining the principal accountant’s independence.
PART IV
Item 15. Exhibits and Financial Statement Schedules.
(a)(1) Financial Statements
The Financial Statements of Mobivity Holdings Corp. and Report of Independent Registered Public Accounting Firm are included in a separate section of this Form 10-K beginning on page F-1.
(a)(2) Financial Statement Schedules
The schedules required to be filed by this item have been omitted because of the absence of conditions under which they are required, or because the required information is included in the financial statements or the notes thereto.
(a)(3) Exhibits
| | |
| | |
Exhibit Number | | Description |
3.1 | | Articles of Incorporation (1) |
3.2 | | Bylaws (1) |
3.3 | | Amendment to Bylaws (2) |
3.4 | | Articles of Merger filed August 6, 2012 (4) |
3.5 | | Amendment No. 2 to the Bylaws, effective as of May 20, 2013 (8) |
3.6 | | Amendment to Articles of Incorporation filed with the Nevada Secretary of State on November 12, 2013 (6) |
4.1 | | Description of Capital Stock* |
10.1 | | Employment Agreement dated December 24, 2010 with Dennis Becker (3)** |
10.2 | | 2013 Stock Incentive Plan of the Company adopted July 18, 2013 (5) ** |
10.3 | | Loan and Security Agreement dated November 14, 2018 between the Company and Wintrust Bank (6) |
10.4 | | Employment Agreement dated December 7, 2020 with Lisa Brennan* ** |
21.1 | | List of Subsidiaries (6) |
31.1 | | Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
31.2 | | Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
32.1 | | Certification of Chief Executive Officer, and Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
101.INS | | XBRL Instance Document* |
101.CAL | | XBRL Taxonomy Extension Calculation Linkbase Document* |
101.LAB | | XBRL Taxonomy Extension Label Linkbase Document* |
101.PRE | | XBRL Taxonomy Extension Presentation Linkbase Document* |
101.DEF | | XBRL Taxonomy Extension Definition Linkbase Document* |
| |
* | Filed herewith |
** | Indicates management compensatory plan, contract or arrangement |
(1) | Incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on October 20, 2008, File No. 333-154455 |
(2) | Incorporated by reference to the Company’s Current Report on Form 8-K filed December 2, 2011 |
(3) | Incorporated by reference to the Company’s Current Report on Form 8-K filed January 18, 2011 |
(4) | Incorporated by reference to the Company’s Current Report on Form 8-K filed August 10, 2012 |
(5) | Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed August 14, 2013 |
(6) | Incorporated by reference to the Company’s Annual Report on Form 10-K filed April 15, 2019 |
| |
| |
| |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
DATE: March 30, 2022 | MOBIVITY HOLDINGS CORP. |
| /s/ Dennis Becker |
| Dennis Becker |
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | | | |
Signature | | Title | | Date |
| | | | |
/s/ Dennis Becker | | Chief Executive Officer and Chairman of the Board | | March 30, 2022 |
| | | | |
/s/ Lisa Brennan | | Chief Financial Officer | | March 30, 2022 |
| | | | |
/s/ Philip Guarascio | | Director | | March 30, 2022 |
| | | | |
/s/ John Harris | | Director | | March 30, 2022 |
| | | | |
/s/ Doug Schneider | | Director | | March 30, 2022 |
| | | | |
/s/ Thomas Akin | | Director | | March 30, 2022 |
| | | | |
Mobivity (QB) (USOTC:MFON)
Historical Stock Chart
From Oct 2024 to Nov 2024
Mobivity (QB) (USOTC:MFON)
Historical Stock Chart
From Nov 2023 to Nov 2024